Smith & Nephew plc ADR

SNNNYSE · USD
27.08USD0.00 (+0.64%)
775

Smith & Nephew plc ADR (SNN) Covered Calls

As of September 25, 2026, SNN has 1 covered call opportunities in the coming three months. Return ranges from 11.9 to 11.9% until expiration. Annualized return ranges from 206.0 to 206.0%. The nearest expiration is October 16, 2026. Maximum potential profit is $319.

Read more

Running SNN covered calls helps you generate consistent income from Smith & Nephew plc ADR's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Smith & Nephew plc ADR involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best SNN covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if SNN stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling SNN covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Smith & Nephew plc ADR covered call is worth writing.

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems.

In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Income-focused investors, long-term SNN holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling SNN covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Smith & Nephew plc ADR covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile29.76% Subdued
  • Market cap (M$)11,334
  • 52 weeks high-27.81%
  • 52 weeks low2.58%
  • Analyst recommendationHold
    3.00
  • Target price$31.81
    17.47% above the current stock price
  • Dividend—
  • Payout ratio52.04%
  • Earnings date2026-08-04
  • P/E18.46
  • Future P/E11.33
  • EPS (ttm)1.47
  • EPS growth next 5 years9.42%

As of September 25, 2026

2026-10-162130.0011.480.100.35319.0011.85206.04-0.37+0.16300.25

As of September 25, 2026

Sell covered calls with the data behind you

Find the best SNN covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial